The Washout Period: The Key to Recovery I wasnt making any progress and wasnt feeling good either
Biguanides, sodium glucose cotransporter 2 (SGLT2) inhibitors, and sulfonylureas were the leading OAD classes, with usage rates of 88.2%, 82.7%, and 30.0%, respectively
The starting dose is typically 20 units (0.24mg AOD + 0.4mg MOTs-C + 0.4mg Tesa + 0.4mg Ipa)
When you know the answers to these four questions, you and your provider can work together to create a plan that works best for your body and your schedule
continuous treatment or maintenance sessions are necessary to uphold results
GLP1/GIP - Tirzepatide Tirzepatide is a dual GLP-1 and GIP receptor agonist that may be prescribed following a comprehensive evaluation with one of our licensed medical providers, when clinically appropriate